Fulcrum Therapeutics, Inc. (FULC) DCF Valuation

Fulcrum Therapeutics, Inc. (FULC) DCF Valuation

US | Healthcare | Biotechnology | NASDAQ
Fulcrum Therapeutics, Inc. (FULC) DCF Valuation
  • ✓ Totalmente Editável: Adapte-Se Às Suas Necessidades No Excel Ou Planilhas
  • ✓ Design Profissional: Modelos Confiáveis ​​E Padrão Da Indústria
  • ✓ Pré-Construídos Para Uso Rápido E Eficiente
  • ✓ Não É Necessária Experiência; Fácil De Seguir

Fulcrum Therapeutics, Inc. (FULC) Bundle

Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Looking to assess the intrinsic value of Fulcrum Therapeutics, Inc.? Our (FULC) DCF Calculator integrates real-world data with comprehensive customization features, allowing you to adjust forecasts and enhance your investment strategies.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue .0 8.8 19.2 6.3 2.8 2.6 2.5 2.4 2.2 2.1
Revenue Growth, % 0 0 117.19 -66.9 -55.77 -5.67 -5.67 -5.67 -5.67 -5.67
EBITDA -82.2 -69.2 -78.5 -109.7 -108.5 -1.6 -1.5 -1.4 -1.3 -1.3
EBITDA, % 100 -784.68 -409.85 -1730.05 -3867.81 -60 -60 -60 -60 -60
Depreciation 2.1 2.4 2.5 2.4 2.2 1.4 1.3 1.2 1.1 1.1
Depreciation, % 100 26.96 13.12 38.06 77.43 51.12 51.12 51.12 51.12 51.12
EBIT -84.2 -71.6 -81.1 -112.1 -110.7 -1.6 -1.5 -1.4 -1.3 -1.3
EBIT, % 100 -811.64 -422.97 -1768.12 -3945.24 -60 -60 -60 -60 -60
Total Cash 96.7 112.9 218.2 202.9 236.2 2.6 2.5 2.4 2.2 2.1
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables .1 2.7 4.1 1.1 2.2
Account Receivables, % 100 30.68 21.45 17.05 80.18
Inventories 3.0 -2.8 -.5 -.9 .0 .3 .3 .2 .2 .2
Inventories, % 100 -31.52 -2.47 -13.43 0 10.52 10.52 10.52 10.52 10.52
Accounts Payable 2.2 4.1 4.8 3.6 2.8 1.7 1.6 1.5 1.5 1.4
Accounts Payable, % 100 46.23 24.99 57.36 98.29 65.37 65.37 65.37 65.37 65.37
Capital Expenditure -.9 -1.3 -1.7 -2.0 -.5 -.4 -.4 -.3 -.3 -.3
Capital Expenditure, % 100 -15.21 -8.94 -30.95 -18.11 -14.64 -14.64 -14.64 -14.64 -14.64
Tax Rate, % 0 0 0 0 0 0 0 0 0 0
EBITAT -80.6 -69.2 -78.5 -107.8 -110.7 -1.5 -1.5 -1.4 -1.3 -1.2
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -80.3 -63.1 -80.7 -105.1 -111.9 -1.0 -.6 -.5 -.5 -.5
WACC, % 14.62 14.62 14.62 14.62 14.62 14.62 14.62 14.62 14.62 14.62
PV UFCF
SUM PV UFCF -2.1
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) 0
Terminal Value -4
Present Terminal Value -2
Enterprise Value -4
Net Debt -15
Equity Value 11
Diluted Shares Outstanding, MM 61
Equity Value Per Share 0.18

What You Will Get

  • Real FULC Financials: Access to historical and projected data for precise valuation.
  • Customizable Inputs: Adjust WACC, tax rates, revenue growth, and capital expenditures to fit your analysis.
  • Instant Calculations: Intrinsic value and NPV are computed automatically.
  • Scenario Analysis: Evaluate various scenarios to assess Fulcrum Therapeutics' future performance.
  • User-Friendly Interface: Designed for professionals while remaining approachable for newcomers.

Key Features

  • Comprehensive FULC Data: Pre-loaded with Fulcrum Therapeutics’ historical financials and future projections.
  • Customizable Input Parameters: Modify revenue growth rates, margins, WACC, tax rates, and capital expenditures to suit your analysis.
  • Interactive Valuation Model: Automatic recalculations of Net Present Value (NPV) and intrinsic value based on your adjustments.
  • Multiple Scenario Analysis: Develop various forecasting scenarios to evaluate different valuation results.
  • Intuitive User Interface: Designed for ease of use, catering to both professionals and novices.

How It Works

  • Step 1: Download the prebuilt Excel template featuring Fulcrum Therapeutics, Inc. (FULC) data.
  • Step 2: Navigate through the pre-filled sheets to familiarize yourself with the essential metrics.
  • Step 3: Adjust forecasts and assumptions in the editable yellow cells (WACC, growth, margins).
  • Step 4: Instantly see recalculated results, including Fulcrum Therapeutics, Inc. (FULC) intrinsic value.
  • Step 5: Make well-informed investment decisions or create reports based on the outputs.

Why Choose Fulcrum Therapeutics, Inc. (FULC)?

  • Innovative Solutions: Focuses on developing transformative therapies for rare genetic diseases.
  • Expert Team: Comprised of industry leaders and experienced professionals dedicated to advancing drug development.
  • Robust Pipeline: Features a diverse range of drug candidates in various stages of clinical trials.
  • Strong Partnerships: Collaborates with leading institutions and organizations to enhance research and development efforts.
  • Commitment to Patients: Prioritizes patient needs and strives to improve quality of life through innovative treatments.

Who Should Use This Product?

  • Pharmaceutical Students: Understand drug development processes and apply them to real-world scenarios.
  • Researchers: Integrate advanced models into studies or academic projects related to therapeutics.
  • Investors: Evaluate your own strategies and assess the market potential for Fulcrum Therapeutics, Inc. (FULC).
  • Healthcare Analysts: Enhance your analysis with a customizable financial model specific to biotech companies.
  • Entrepreneurs: Discover how large biotech firms like Fulcrum Therapeutics, Inc. (FULC) navigate the market landscape.

What the Template Contains

  • Pre-Filled DCF Model: Fulcrum Therapeutics' financial data preloaded for immediate use.
  • WACC Calculator: Detailed calculations for Weighted Average Cost of Capital.
  • Financial Ratios: Evaluate Fulcrum Therapeutics' profitability, leverage, and efficiency.
  • Editable Inputs: Change assumptions such as growth, margins, and CAPEX to fit your scenarios.
  • Financial Statements: Annual and quarterly reports to support detailed analysis.
  • Interactive Dashboard: Easily visualize key valuation metrics and results.

No products were found matching.